LISA MEDEIROS: Open Payments
NPI 1881911709 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 46 payments from 14 companies in 2025. Trend: 2023 $1,221 · 2024 $1,400 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $548 |
| Ardelyx, Inc. | 4 | $109 |
| Janssen Biotech, Inc. | 3 | $82 |
| GENZYME CORPORATION | 3 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| PFIZER INC. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Intercept Pharmaceuticals, Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: RINVOQ, SKYRIZI, IBSRELA, DUPIXENT, LINZESS, TREMFYA, XIFAXAN, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
